ATF3 also suppresses bladder cancer metastasis through promoting gelsolin-mediated actin remodeling (Yuan et al. 2013) and maintains genomic stability by activating ataxia telangiectasia mutated (ATM) signaling (Cui et al. 2015). Here, ATM is linked to urinary bladder carcinoma.